Literature DB >> 11150295

Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate.

T Fujino1, J Kondo, M Ishikawa, K Morikawa, T T Yamamoto.   

Abstract

Using peptide sequences derived from bovine cardiac acetyl-CoA synthetase (AceCS), we isolated and characterized cDNAs for a bovine and murine cardiac enzyme designated AceCS2. We also isolated a murine cDNA encoding a hepatic type enzyme, designated AceCS1, identical to one reported recently (Luong, A., Hannah, V. C., Brown, M. S., and Goldstein, J. L. (2000) J. Biol. Chem. 275, 26458-26466). Murine AceCS1 and AceCS2 were purified to homogeneity and characterized. Among C2-C5 short and medium chain fatty acids, both enzymes preferentially utilize acetate with similar affinity. The AceCS2 transcripts are expressed in a wide range of tissues, with the highest levels in heart, and are apparently absent from the liver. The levels of AceCS2 mRNA in skeletal muscle were increased markedly under ketogenic conditions. Subcellular fractionation revealed that AceCS2 is a mitochondrial matrix enzyme. [(14)C]Acetate incorporation indicated that acetyl-CoAs produced by AceCS2 are utilized mainly for oxidation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11150295     DOI: 10.1074/jbc.M008782200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  108 in total

1.  Nuclear-cytoplasmic localization of acetyl coenzyme a synthetase-1 in the rat brain.

Authors:  Prasanth S Ariyannur; John R Moffett; Chikkathur N Madhavarao; Peethambaran Arun; Nisha Vishnu; David M Jacobowitz; William C Hallows; John M Denu; Aryan M A Namboodiri
Journal:  J Comp Neurol       Date:  2010-08-01       Impact factor: 3.215

Review 2.  Reversible acetylation of PGC-1: connecting energy sensors and effectors to guarantee metabolic flexibility.

Authors:  E H Jeninga; K Schoonjans; J Auwerx
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

3.  Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation.

Authors:  Chris J Reisenauer; Dhaval P Bhatt; Dane J Mitteness; Evan R Slanczka; Heidi M Gienger; John A Watt; Thad A Rosenberger
Journal:  J Neurochem       Date:  2011-02-24       Impact factor: 5.372

Review 4.  Emerging characterization of the role of SIRT3-mediated mitochondrial protein deacetylation in the heart.

Authors:  Michael N Sack
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-07       Impact factor: 4.733

Review 5.  Mitochondrial SIRT3 and heart disease.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Valluvan Jeevanandam; Mahesh P Gupta
Journal:  Cardiovasc Res       Date:  2010-08-04       Impact factor: 10.787

Review 6.  Protein acetylation in metabolism - metabolites and cofactors.

Authors:  Keir J Menzies; Hongbo Zhang; Elena Katsyuba; Johan Auwerx
Journal:  Nat Rev Endocrinol       Date:  2015-10-27       Impact factor: 43.330

7.  Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma.

Authors:  Andrew R Tsen; Patrick M Long; Heather E Driscoll; Matthew T Davies; Benjamin A Teasdale; Paul L Penar; William W Pendlebury; Jeffrey L Spees; Sean E Lawler; Mariano S Viapiano; Diane M Jaworski
Journal:  Int J Cancer       Date:  2013-09-30       Impact factor: 7.396

Review 8.  The acetate switch.

Authors:  Alan J Wolfe
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

9.  Sirtuins: a conserved key unlocking AceCS activity.

Authors:  Brian J North; David A Sinclair
Journal:  Trends Biochem Sci       Date:  2006-12-01       Impact factor: 13.807

Review 10.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.